Images
Contact
The journalist Kathryn Senior, working for the science journal The Lancet Oncology, devotes an article to the cut-backs in research announced for 2012 in Spain, Canada and the Ukraine and the uncertain future for researchers working in these countries. The director of IRB Barcelona, Joan J. Guinovart, is one of the scientists consulted to talk about the situation in Spain. Guinovart describes the situation as “dramatic” and urges members of parliament to correct it when the budgets pass through parliament. Furthermore, Guinovart defends that “the crisis serve as a stimulus to reform the science and technology system in Spain and that, for example, a National Research Agency, like the European Research Council (ERC), be set up, as included in the recently passed Science Law.
Reference article:
The Lancet Oncology. Early Online Publication, 13 April 2012
Doi: 10.1016/S1470-2045(12)70163-8
Link to The Lancet Oncology
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
